News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeuroMetrix, Inc. (NURO) to Exhibit at American Diabetes Association 72nd Scientific Sessions


5/31/2012 10:26:05 AM

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that it will exhibit and participate in the American Diabetes Association (ADA) 72nd Scientific Sessions. The ADA Scientific Sessions will be held on June 8-12 in Philadelphia at the Pennsylvania Convention Center.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES